Cell Society International Hosts its 2nd Annual Clinical Conference in San Diego, CA, to Discuss Clinical Advancements …

LA JOLLA, Calif., Jan. 25, 2012 /PRNewswire/ -- Interest
in adult stem cell therapies and their clinical applicability
in treating and helping patients is growing, while accurate
information remains difficult to access.  Cell Society
International^[1], a
nonprofit organization, is dedicated to advancing the
clinical applications of adult stem cell therapies worldwide
through education and the collaboration of world thought
leaders.

According to Emerson C. Perin, MD, PhD, Director, Clinical
Research for Cardiovascular Medicine and Medical Director,
Stem Cell Institute, Texas Heart Institute, Houston, TX and
member of the Board of Directors of Cell Society, "We
obtained remarkable results from our study in which we
injected stem cells derived from the bone marrow of a healthy
donor into patients with heart failure. Heart function and
exercise capacity improved in some cell-treated patients.
Most importantly, cell therapy significantly reduced cardiac
adverse events, including death. Three of 15 (20%) control
patients died of cardiac causes, whereas only 1 of 45 (2%)
cell-treated patients had a cardiac-related death. Despite
the small numbers, our findings showed that cell therapy
significantly improved cardiac mortality." 

The 2nd Annual Clinical Meeting of Cell Society will be held
at the Coronado Island Marriott Resort in San Diego,
California on February 17 – 18, 2012.  International and
national clinical researchers and thought leaders will share
current information on adult stem cell applications in a
variety of therapeutic categories The two-day conference will
offer clinical updates on cell therapies in plastic surgery,
wound healing, cardiac disease, stroke, MS, bone healing and
cartilage regeneration, to name a few, as well as industry
updates from leading developers of cell therapies and medical
devices.  The second day includes a panel discussion
titled The Practice of Medicine and Government
Regulation: The Rubicon as well as a session focused on
the Future of Stem Cell Therapy in the United
States. Leading experts from around the globe will
discuss the challenges facing all who are involved in the
advancement of regenerative medicine through the use of stem
cell therapy.  Up to 11.5 CME credits will be available
for attendees.

About Cell Society International:  Cell Society was
formed in May 2010, to serve as an independent source of
educational information for all interested in clinically
relevant adult stem cell therapy applications.  As a
nonprofit mutual benefit corporation, Cell Society will
utilize the expertise of its industry relationships as well
as the cooperation of patients, their physicians and world
thought leaders to advance the clinical applications of adult
stem cell therapies worldwide.  For more information
about registration and sponsorship for the 2nd Annual
Clinical Meeting please visit http://xmedicacme.com/cell_society or
contact info@xMedicaCME.com^[2][3]